APAC Drug modeling software Market - Industry Trends and Forecast to 2030

List of Tables

Asia-Pacific drug modeling software market is expected to reach USD 1,999.99 million by 2030 from USD 1,085.16 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2033.

Market Segmentation:

Asia-Pacific Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country (China, Japan , South Korea , India , Australia , Singapore, Thailand , Indonesia , Philippines , Malaysia , New Zealand , Vietnam , Taiwan, Rest Of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific Drug Modeling Software Market Dynamics :

Driver
Rising drug discovery and development activities
Restrain
Lack of quality data base
Opportunity
Cloud computing and big data analytics in drug modelling

Market Players:

The key market players operating in the Asia-Pacific drug modeling software market are listed below:

Dassault Systemes
Amazon Web Services, Inc.
Certara, USA.
Schrodinger, Inc.
Cresset.
SIMULATIONS PLUS.
Others

1 INTRODUCTION 57

1.1 OBJECTIVES OF THE STUDY 57
1.2 MARKET DEFINITION 57
1.3 OVERVIEW OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET 57
1.4 CURRENCY AND PRICING 59
1.5 LIMITATIONS 59
1.6 MARKETS COVERED 59

2 MARKET SEGMENTATION 62

2.1 MARKETS COVERED 62
2.2 GEOGRAPHICAL SCOPE 63
2.3 YEARS CONSIDERED FOR THE STUDY 64
2.4 DBMR TRIPOD DATA VALIDATION MODEL 65
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 68
2.6 MULTIVARIATE MODELING 69
2.7 COMPONENT LIFELINE CURVE 69
2.8 DBMR MARKET POSITION GRID 70
2.9 VENDOR SHARE ANALYSIS 71
2.10 MARKET APPLICATION COVERAGE GRID 72
2.11 SECONDARY SOURCES 73
2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

3.1 PORTER'S FIVE FORCES MODEL 78
3.2 VALUE CHAIN ANALYSIS 79
3.3 REGULATORY STANDARDS 80
3.4 TECHNOLOGICAL TRENDS 81
3.5 BENEFITS OF DRUG MODELING SOFTWARE 82

4 MARKET OVERVIEW 83

4.1 DRIVERS 85
- 4.1.1 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 85
- 4.1.2 RISING DEMAND FOR NOVEL THERAPIES 87
- 4.1.3 PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING 88
4.2 RESTRAINTS 89
- 4.2.1 LACK OF QUALITY DATA BASE 89
- 4.2.2 HIGH COST OF MANUFACTURING OF DRUG MODELLING SOFTWARE 89
4.3 OPPORTUNITIES 90
- 4.3.1 CLOUD COMPUTING AND BIG DATA ANALYTICS IN DRUG MODELLING 90
- 4.3.2 INCREASING ADOPTION OF MODELLING TOOLS IN DRUG DISCOVERY 91
4.4 CHALLENGES 91
- 4.4.1 LACK OF PROCEDURE FOR MULTI-DRUG EFFECT ASSESMENT 91
- 4.4.2 CHALLENGES WITH MODEL INTERPRETATION 92

5 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS 93

5.1 OVERVIEW 94
- 5.1.1 SOFTWARE 97
  - 5.1.1.1 INTEGRATED 98
  - 5.1.1.2 STANDALONE 98
  - 5.1.1.3 LIGAND BASED 98
  - 5.1.1.4 STRUCTURE BASED 98
5.2 SERVICES 98
- 5.2.1 PROFESSIONAL SERVICES 99
  - 5.2.1.1 CONSULTING AND TRAINING 100
  - 5.2.1.2 INTEGRATION AND IMPLEMENTATION 100
  - 5.2.1.3 SUPPORT AND MAINTENANCE 100
- 5.2.2 MANAGED SERVICES 100

6 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM 101

6.1 OVERVIEW 102
6.2 WINDOWS 105
6.3 LINUX 105
6.4 MAC OS 106
6.5 OTHERS 107

7 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE 108

7.1 OVERVIEW 109
7.2 CLOUD BASED 112
7.3 HYBRID-BASED 112
7.4 ON-PREMISES 113

8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE 114

8.1 OVERVIEW 115
8.2 LARGE ENTERPRISE SIZE 118
8.3 SMALL & MEDIUM ENTERPRISE SIZE 118

9 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION 120

9.1 OVERVIEW 121
9.2 GRAPHICAL MOLECULAR MODELING 124
9.3 GENE SEQUENCE ANALYSIS 124
9.4 PROTEIN MODELING 125
9.5 MODELING CRYSTAL STRUCTURES 126
9.6 CHEMINFORMATICS 127
9.7 HIGH THROUGHPUT VIRTUAL SCREENING 128
9.8 GAS & SOLUTION PHASE REACTION 128
9.9 MEDICAL IMAGING 129
9.10 OTHERS 130

10 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL 131

10.1 OVERVIEW 132
10.2 SUBSCRIPTION BASED 135
- 10.2.1 ANNUALLY SUBSCRIPTION 136
- 10.2.2 MONTHLY SUBSCRIPTION 136
10.3 ONE-TIME LICENSE 136
- 10.3.1 GROUP LICENSE 137
- 10.3.2 DESKTOP LICENSE 137
- 10.3.3 OTHERS 137

11 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER 138

11.1 OVERVIEW 139
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 142
- 11.2.1 LARGE ENTERPRISE SIZE 143
- 11.2.2 SMALL & MEDIUM ENTERPRISE SIZE 143
11.3 CONTRACT RESEARCH ORGANIZATIONS 143
- 11.3.1 LARGE ENTERPRISE SIZE 144
- 11.3.2 SMALL & MEDIUM ENTERPRISE SIZE 144
11.4 RESEARCH INSTITUTES 144
- 11.4.1 LARGE ENTERPRISE SIZE 145
- 11.4.2 SMALL & MEDIUM ENTERPRISE SIZE 145
11.5 REGULATORY AUTHORITIES 145
- 11.5.1 LARGE ENTERPRISE SIZE 146
- 11.5.2 SMALL & MEDIUM ENTERPRISE SIZE 147
11.6 OTHERS 147
- 11.6.1 LARGE ENTERPRISE SIZE 148
- 11.6.2 SMALL & MEDIUM ENTERPRISE SIZE 148

12 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY REGION 149

12.1 ASIA-PACIFIC 150
- 12.1.1 CHINA 161
- 12.1.2 JAPAN 166
- 12.1.3 SOUTH KOREA 171
- 12.1.4 INDIA 176
- 12.1.5 AUSTRALIA 181
- 12.1.6 SINGAPORE 186
- 12.1.7 THAILAND 191
- 12.1.8 INDONESIA 196
- 12.1.9 PHILIPPINES 201
- 12.1.10 MALAYSIA 206
- 12.1.11 NEW ZEALAND 211
- 12.1.12 VIETNAM 216
- 12.1.13 TAIWAN 221
- 12.1.14 REST OF ASIA-PACIFIC 226

13 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY LANDSCAPE 227

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 227

14 SWOT ANALYSIS 228

15 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, COMPANY PROFILE 229

15.1 DASSAULT SYSTEMES 229
- 15.1.1 COMPANY SNAPSHOT 229
- 15.1.2 REVENUE ANALYSIS 229
- 15.1.3 COMPANY SHARE ANALYSIS 230
- 15.1.4 PRODUCT PORTFOLIO 230
- 15.1.5 RECENT DEVELOPMENT 230
15.2 AMAZON WEB SERVICES, INC. OR ITS AFFILIATES.(A SUBSIDIARY OF AMAZON) 231
- 15.2.1 COMPANY SNAPSHOT 231
- 15.2.2 REVENUE ANALYSIS 231
- 15.2.3 COMPANY SHARE ANALYSIS 232
- 15.2.4 PRODUCT PORTFOLIO 232
- 15.2.5 RECENT DEVELOPMENTS 232
15.3 CERTARA, USA. 233
- 15.3.1 COMPANY SNAPSHOT 233
- 15.3.2 REVENUE ANALYSIS 233
- 15.3.3 COMPANY SHARE ANALYSIS 234
- 15.3.4 PRODUCT PORTFOLIO 234
- 15.3.5 RECENT DEVELOPMENTS 234
15.4 SCHRODINGER, INC. 235
- 15.4.1 COMPANY SNAPSHOT 235
- 15.4.2 REVENUE ANALYSIS 235
- 15.4.3 COMPANY SHARE ANALYSIS 236
- 15.4.4 PRODUCT PORTFOLIO 236
- 15.4.5 RECENT DEVELOPMENT 236
15.5 CRESSET. 237
- 15.5.1 COMPANY SNAPSHOT 237
- 15.5.2 COMPANY SHARE ANALYSIS 237
- 15.5.3 PRODUCT PORTFOLIO 238
- 15.5.4 RECENT DEVELOPMENTS 238
15.6 ACELLERA LTD 239
- 15.6.1 COMPANY SNAPSHOT 239
- 15.6.2 PRODUCT PORTFOLIO 239
- 15.6.3 RECENT DEVELOPMENTS 239
15.7 ARGUSLAB 240
- 15.7.1 COMPANY SNAPSHOT 240
- 15.7.2 PRODUCT PORTFOLIO 240
- 15.7.3 RECENT DEVELOPMENT 240
15.8 ATOMWISE INC. 241
- 15.8.1 COMPANY SNAPSHOT 241
- 15.8.2 PRODUCT PORTFOLIO 241
- 15.8.3 RECENT DEVELOPMENT 241
15.9 BC PLATFORMS 242
- 15.9.1 COMPANY SNAPSHOT 242
- 15.9.2 PRODUCT PORTFOLIO 242
- 15.9.3 RECENT DEVELOPMENTS 243
15.10 BIOSOLVEIT GMBH 244
- 15.10.1 COMPANY SNAPSHOT 244
- 15.10.2 PRODUCT PORTFOLIO 244
- 15.10.3 RECENT DEVELOPMENT 244
15.11 DOTMATICS 245
- 15.11.1 COMPANY SNAPSHOT 245
- 15.11.2 PRODUCT PORTFOLIO 245
- 15.11.3 RECENT DEVELOPMENTS 246
15.12 GENECODE 247
- 15.12.1 COMPANY SNAPSHOT 247
- 15.12.2 PRODUCT PORTFOLIO 247
- 15.12.3 RECENT DEVELOPMENT 247
15.13 INSILICOTRIALS TECHNOLOGIES. 248
- 15.13.1 COMPANY SNAPSHOT 248
- 15.13.2 PRODUCT PORTFOLIO 248
- 15.13.3 RECENT DEVELOPMENTS 249
15.14 NANOME INC. 250
- 15.14.1 COMPANY SNAPSHOT 250
- 15.14.2 PRODUCT PORTFOLIO 250
- 15.14.3 RECENT DEVELOPMENT 250
15.15 OPTIBRIUM, LTD. 251
- 15.15.1 COMPANY SNAPSHOT 251
- 15.15.2 PRODUCT PORTFOLIO 251
- 15.15.3 RECENT DEVELOPMENT 251
15.16 PHARMACELERA 252
- 15.16.1 COMPANY SNAPSHOT 252
- 15.16.2 PRODUCT PORTFOLIO 252
- 15.16.3 RECENT DEVELOPMENT 252
15.17 SIMULATIONS PLUS. 253
- 15.17.1 COMPANY SNAPSHOT 253
- 15.17.2 REVENUE ANALYSIS 254
- 15.17.3 COMPANY SHARE ANALYSIS 255
- 15.17.4 PRODUCT PORTFOLIO 255
- 15.17.5 RECENT DEVELOPMENT 256
15.18 THE SCRIPPS RESEARCH INSTITUTE 257
- 15.18.1 COMPANY SNAPSHOT 257
- 15.18.2 PRODUCT PORTFOLIO 257
- 15.18.3 RECENT DEVELOPMENT 257
15.19 VERISIM LIFE. 258
- 15.19.1 COMPANY SNAPSHOT 258
- 15.19.2 PRODUCT PORTFOLIO 258
- 15.19.3 RECENT DEVELOPMENTS 258
15.20 XTALPI INC. 259
- 15.20.1 COMPANY SNAPSHOT 259
- 15.20.2 PRODUCT PORTFOLIO 259
- 15.20.3 RECENT DEVELOPMENT 259
15.21 XYBION DIGITAL INC. 260
- 15.21.1 COMPANY SNAPSHOT 260
- 15.21.2 REVENUE ANALYSIS 260
- 15.21.3 PRODUCT PORTFOLIO 261
- 15.21.4 RECENT DEVELOPMENT 261

16 QUESTIONNAIRE 262

17 RELATED REPORTS 266

LIST OF TABLES

TABLE 1 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 67
TABLE 2 ASIA PACIFIC SOFTAWARE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 3 ASIA PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
TABLE 4 ASIA PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 69
TABLE 5 ASIA PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 70
TABLE 6 ASIA PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 70
TABLE 7 ASIA PACIFIC PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 71
TABLE 8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 75
TABLE 9 ASIA PACIFIC WINDOWS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 10 ASIA PACIFIC LINUX IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 11 ASIA PACIFIC MAC OS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 12 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 13 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 82
TABLE 14 ASIA PACIFIC CLOUD BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 15 ASIA PACIFIC HYBRID-BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 16 ASIA PACIFIC ON-PREMISES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 17 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 88
TABLE 18 ASIA PACIFIC LARGE ENTERPRISE SIZE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 19 ASIA PACIFIC SMALL & MEDIUM ENTERPRISE SIZE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 20 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
TABLE 21 ASIA PACIFIC GRAPHICAL MOLECULAR MODELING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 22 ASIA PACIFIC GENE SEQUENCE ANALYSIS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 23 ASIA PACIFIC PROTEIN MODELING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 24 ASIA PACIFIC MODELING CRYSTAL STRUCTURES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 25 ASIA PACIFIC CHEMINFORMATICS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 26 ASIA PACIFIC HIGH THROUGHPUT VIRTUAL SCREENING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 99
TABLE 27 ASIA PACIFIC GAS & SOLUTION PHASE REACTION IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 28 ASIA PACIFIC MEDICAL IMAGING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 29 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 30 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 105
TABLE 31 ASIA PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 106
TABLE 32 ASIA PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 106
TABLE 33 ASIA PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 34 ASIA PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 108
TABLE 35 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 112
TABLE 36 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 37 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 113
TABLE 38 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 114
TABLE 39 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 115
TABLE 40 ASIA PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 41 ASIA PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 116
TABLE 42 ASIA PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 117
TABLE 43 ASIA PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 117
TABLE 44 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 118
TABLE 45 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 118
TABLE 46 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 126
TABLE 47 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 126
TABLE 48 ASIA-PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 49 ASIA-PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
TABLE 50 ASIA-PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
TABLE 51 ASIA-PACIFIC PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
TABLE 52 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 127
TABLE 53 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 128
TABLE 54 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 128
TABLE 55 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
TABLE 56 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
TABLE 57 ASIA-PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
TABLE 58 ASIA-PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
TABLE 59 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 129
TABLE 60 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
TABLE 61 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
TABLE 62 ASIA-PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
TABLE 63 ASIA-PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
TABLE 64 ASIA-PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 131
TABLE 65 CHINA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 132
TABLE 66 CHINA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 67 CHINA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
TABLE 68 CHINA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
TABLE 69 CHINA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
TABLE 70 CHINA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 133
TABLE 71 CHINA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 133
TABLE 72 CHINA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 133
TABLE 73 CHINA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
TABLE 74 CHINA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 134
TABLE 75 CHINA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 134
TABLE 76 CHINA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 135
TABLE 77 CHINA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 135
TABLE 78 CHINA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 135
TABLE 79 CHINA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 135
TABLE 80 CHINA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
TABLE 81 CHINA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
TABLE 82 CHINA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
TABLE 83 JAPAN DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 137
TABLE 84 JAPAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 85 JAPAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
TABLE 86 JAPAN SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
TABLE 87 JAPAN PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 138
TABLE 88 JAPAN DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 138
TABLE 89 JAPAN DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 138
TABLE 90 JAPAN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 138
TABLE 91 JAPAN DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
TABLE 92 JAPAN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 139
TABLE 93 JAPAN SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 139
TABLE 94 JAPAN ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 140
TABLE 95 JAPAN DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 96 JAPAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 140
TABLE 97 JAPAN CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 140
TABLE 98 JAPAN RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
TABLE 99 JAPAN REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
TABLE 100 JAPAN OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
TABLE 101 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 142
TABLE 102 SOUTH KOREA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 103 SOUTH KOREA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 142
TABLE 104 SOUTH KOREA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 142
TABLE 105 SOUTH KOREA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 143
TABLE 106 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 143
TABLE 107 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 143
TABLE 108 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 143
TABLE 109 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 110 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 144
TABLE 111 SOUTH KOREA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 144
TABLE 112 SOUTH KOREA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 145
TABLE 113 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 145
TABLE 114 SOUTH KOREA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 145
TABLE 115 SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
TABLE 116 SOUTH KOREA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
TABLE 117 SOUTH KOREA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
TABLE 118 SOUTH KOREA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
TABLE 119 INDIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 147
TABLE 120 INDIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 121 INDIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
TABLE 122 INDIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
TABLE 123 INDIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 148
TABLE 124 INDIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 148
TABLE 125 INDIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 148
TABLE 126 INDIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 148
TABLE 127 INDIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 128 INDIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 149
TABLE 129 INDIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 149
TABLE 130 INDIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 150
TABLE 131 INDIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 150
TABLE 132 INDIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 150
TABLE 133 INDIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 150
TABLE 134 INDIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
TABLE 135 INDIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
TABLE 136 INDIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
TABLE 137 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 152
TABLE 138 AUSTRALIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
TABLE 139 AUSTRALIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
TABLE 140 AUSTRALIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
TABLE 141 AUSTRALIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
TABLE 142 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 153
TABLE 143 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 153
TABLE 144 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 153
TABLE 145 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
TABLE 146 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 154
TABLE 147 AUSTRALIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 154
TABLE 148 AUSTRALIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 155
TABLE 149 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 155
TABLE 150 AUSTRALIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 155
TABLE 151 AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 155
TABLE 152 AUSTRALIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
TABLE 153 AUSTRALIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
TABLE 154 AUSTRALIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
TABLE 155 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 157
TABLE 156 SINGAPORE SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 157 SINGAPORE SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
TABLE 158 SINGAPORE SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
TABLE 159 SINGAPORE PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 158
TABLE 160 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 158
TABLE 161 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 158
TABLE 162 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 158
TABLE 163 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 164 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 159
TABLE 165 SINGAPORE SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 159
TABLE 166 SINGAPORE ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 160
TABLE 167 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 160
TABLE 168 SINGAPORE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 160
TABLE 169 SINGAPORE CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
TABLE 170 SINGAPORE RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
TABLE 171 SINGAPORE REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
TABLE 172 SINGAPORE OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
TABLE 173 THAILAND DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 162
TABLE 174 THAILAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 175 THAILAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
TABLE 176 THAILAND SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
TABLE 177 THAILAND PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 163

TABLE 178 THAILAND DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 163
TABLE 179 THAILAND DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 163
TABLE 180 THAILAND DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 163
TABLE 181 THAILAND DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 164
TABLE 182 THAILAND DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 164
TABLE 183 THAILAND SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 164
TABLE 184 THAILAND ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 165
TABLE 185 THAILAND DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 165
TABLE 186 THAILAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 165
TABLE 187 THAILAND CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 165
TABLE 188 THAILAND RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
TABLE 189 THAILAND REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
TABLE 190 THAILAND OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
TABLE 191 INDONESIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 167
TABLE 192 INDONESIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 193 INDONESIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
TABLE 194 INDONESIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
TABLE 195 INDONESIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 168
TABLE 196 INDONESIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 168
TABLE 197 INDONESIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 168
TABLE 198 INDONESIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 168
TABLE 199 INDONESIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 169
TABLE 200 INDONESIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 169
TABLE 201 INDONESIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 169
TABLE 202 INDONESIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 170
TABLE 203 INDONESIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 170
TABLE 204 INDONESIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 170
TABLE 205 INDONESIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 170
TABLE 206 INDONESIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
TABLE 207 INDONESIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
TABLE 208 INDONESIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
TABLE 209 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 172
TABLE 210 PHILIPPINES SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
TABLE 211 PHILIPPINES SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
TABLE 212 PHILIPPINES SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
TABLE 213 PHILIPPINES PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
TABLE 214 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 173
TABLE 215 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 173
TABLE 216 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 173
TABLE 217 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 174
TABLE 218 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 174
TABLE 219 PHILIPPINES SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 174
TABLE 220 PHILIPPINES ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 175
TABLE 221 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 175
TABLE 222 PHILIPPINES PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 175
TABLE 223 PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
TABLE 224 PHILIPPINES RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
TABLE 225 PHILIPPINES REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
TABLE 226 PHILIPPINES OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
TABLE 227 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 177
TABLE 228 MALAYSIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
TABLE 229 MALAYSIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
TABLE 230 MALAYSIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
TABLE 231 MALAYSIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
TABLE 232 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 178
TABLE 233 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 178
TABLE 234 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 178
TABLE 235 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
TABLE 236 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 179
TABLE 237 MALAYSIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 179
TABLE 238 MALAYSIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 180
TABLE 239 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 180
TABLE 240 MALAYSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 180
TABLE 241 MALAYSIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 180
TABLE 242 MALAYSIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
TABLE 243 MALAYSIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
TABLE 244 MALAYSIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
TABLE 245 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 182
TABLE 246 NEW ZEALAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
TABLE 247 NEW ZEALAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
TABLE 248 NEW ZEALAND SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
TABLE 249 NEW ZEALAND PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 183
TABLE 250 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 183
TABLE 251 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 183
TABLE 252 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 183
TABLE 253 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 254 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 184
TABLE 255 NEW ZEALAND SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 184
TABLE 256 NEW ZEALAND ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 185
TABLE 257 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 185
TABLE 258 NEW ZEALAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 185
TABLE 259 NEW ZEALAND CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
TABLE 260 NEW ZEALAND RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
TABLE 261 NEW ZEALAND REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
TABLE 262 NEW ZEALAND OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
TABLE 263 VIETNAM DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 187
TABLE 264 VIETNAM SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
TABLE 265 VIETNAM SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
TABLE 266 VIETNAM SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
TABLE 267 VIETNAM PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
TABLE 268 VIETNAM DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 188
TABLE 269 VIETNAM DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 188
TABLE 270 VIETNAM DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 188
TABLE 271 VIETNAM DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
TABLE 272 VIETNAM DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 189
TABLE 273 VIETNAM SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 189
TABLE 274 VIETNAM ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 190
TABLE 275 VIETNAM DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 190
TABLE 276 VIETNAM PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 190
TABLE 277 VIETNAM CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
TABLE 278 VIETNAM RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
TABLE 279 VIETNAM REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
TABLE 280 VIETNAM OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
TABLE 281 TAIWAN DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 192
TABLE 282 TAIWAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
TABLE 283 TAIWAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
TABLE 284 TAIWAN SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
TABLE 285 TAIWAN PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
TABLE 286 TAIWAN DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 193
TABLE 287 TAIWAN DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 193
TABLE 288 TAIWAN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 193
TABLE 289 TAIWAN DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 194
TABLE 290 TAIWAN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 194
TABLE 291 TAIWAN SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 194
TABLE 292 TAIWAN ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 195
TABLE 293 TAIWAN DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 195
TABLE 294 TAIWAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 195
TABLE 295 TAIWAN CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 195
TABLE 296 TAIWAN RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
TABLE 297 TAIWAN REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
TABLE 298 TAIWAN OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
TABLE 299 REST OF ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 197

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: SEGMENTATION 31
FIGURE 2 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DATA TRIANGULATION 34
FIGURE 3 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DROC ANALYSIS 35
FIGURE 4 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: ASIA PACIFIC VS. REGIONAL MARKET ANALYSIS 36
FIGURE 5 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS 36
FIGURE 6 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS 37
FIGURE 7 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: MULTIVARIATE MODELING 38
FIGURE 8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DBMR MARKET POSITION GRID 39
FIGURE 9 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: VENDOR SHARE ANALYSIS 40
FIGURE 10 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: MARKET APPLICATION COVERAGE GRID 41
FIGURE 11 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: SEGMENTATION 45
FIGURE 12 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES, RISING DEMAND FOR NOVEL THERAPIES, AND PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING ARE ARE EXPECTED TO DRIVE THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2030 46
FIGURE 13 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET IN 2023 & 2030 46
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET 53
FIGURE 15 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, 2022 63
FIGURE 16 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, 2023-2030 (USD MILLION) 64
FIGURE 17 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, CAGR (2023-2030) 64
FIGURE 18 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, LIFELINE CURVE 65
FIGURE 19 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, 2022 71
FIGURE 20 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, 2023-2030 (USD MILLION) 72
FIGURE 21 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, CAGR (2023-2030) 72
FIGURE 22 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, LIFELINE CURVE 73
FIGURE 23 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, 2022 78
FIGURE 24 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, 2023-2030 (USD MILLION) 79
FIGURE 25 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, CAGR (2023-2030) 79
FIGURE 26 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, LIFELINE CURVE 80
FIGURE 27 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, 2022 84
FIGURE 28 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, 2023-2030 (USD MILLION) 85
FIGURE 29 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, CAGR (2023-2030) 85
FIGURE 30 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, LIFELINE CURVE 86
FIGURE 31 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, 2022 90
FIGURE 32 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 91
FIGURE 33 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, CAGR (2023-2030) 91
FIGURE 34 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, LIFELINE CURVE 92
FIGURE 35 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, 2022 101
FIGURE 36 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, 2023-2030 (USD MILLION) 102
FIGURE 37 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, CAGR (2023-2030) 102
FIGURE 38 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, LIFELINE CURVE 103
FIGURE 39 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, 2022 108
FIGURE 40 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, 2023-2030 (USD MILLION) 109
FIGURE 41 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, CAGR (2023-2030) 109
FIGURE 42 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, LIFELINE CURVE 110
FIGURE 43 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: SNAPSHOT (2022) 120
FIGURE 44 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COUNTRY (2022) 122
FIGURE 45 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COUNTRY (2023 & 2030) 122
FIGURE 46 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS (2023-2030) 123
FIGURE 47 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY SHARE 2022 (%) 196